5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats

Psychopharmacology

Volumn 124, Issue 1-2, 1996, Pages 95-106

  Kehne, John H ^a   Padich, Robert A ^a   McCloskey, Timothy C ^a   Taylor, Vicki L ^a   Schmidt, Christopher J ^a  

^a SANOFI   (France)

Author keywords

3,4 Methylenedioxymethamphetamine, MDMA; Clonidine; Fenfluramine; N Ethyl 3,4 methylenedioxymethamphetamine, MDEA; p Chloramphetamine, PCA; Prepulse inhibition; Schizophrenia; Sensorimotor gating; Serotonin; Wistar rats

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORAMPHETAMINE; CLONIDINE; FENFLURAMINE; MDL 28618A; N ETHYL 3,4 METHYLENEDIOXYAMPHETAMINE; SEROTONIN; SEROTONIN RELEASING AGENT; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; BRAIN CORTEX; CONTROLLED STUDY; DEPLETION; DRUG ANTAGONISM; INTRAPERITONEAL DRUG ADMINISTRATION; LIGHT; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; SEROTONINERGIC SYSTEM; SOUND; STARTLE REFLEX; VISUAL STIMULATION;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FENFLURAMINE; MALE; P-CHLOROAMPHETAMINE; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGENTS; STARTLE REACTION;

EID: 0029940907     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02245609     Document Type: Article

References (59)

1. Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1-8
2. Berger UV, Gu XF, Azmitia EC (1992) The substituted amphetamines 3,4-methyledioxymethamphetamine, methamphetamine, p-chloroamphetamine, and fenfluramine induce 5-hydroxy-tryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153-160
3. Braff DL, Geyer MA (1989) Sensorimotor gating and the neurobiology of schizophrenia: human and animal model studies. In: Schultz S, Tamminga C (eds) Schizophrenia: scientific progress. Oxford University Press, NY, pp 124-136
4. Breier A (1995) Serotonin, schizophrenia and antipsychotic drug action. Schizophr Res 14:187-202
5. Cadenhead KS, Geyer MA, Swerdlow NR (1993) Impaired startle prepulse inhibition and habituation in schizoptypal patients. Am J Psychiatry 150:1862-1867
6. Callaway CW, Wing LL, Nichols DE, Geyer MA (1993) Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release. Psychopharmacology 111:169-178
7. Climko RP, Roehrich H, Sweeney DR, Al-Razi J (1989) Ecstasy: a review of MDMA and MDA. Int J Psychiatry Med 16:359-372
8. Cregge RJ, Wagner ER, Freedman J, Margolin AL (1990) Lipase-catalyzed transesterification in the synthesis of a new chiral unlabeled and carbon-14 labeled serotonin uptake inhibitor. J Org Chem 55:4237-4238
9. 2-adrenergic agonists clonidine and ST-91 on the acoustic startle reflex. Pharmacol Biochem Behav 33:233-240
10. Davis M, Mansbach RS, Swerdlow NR, Campeau S, Braff DL, Geyer MA (1990) Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulse in rats. Psychopharmacology 102:1-4
11. Freedman JM, Dudley M, Baron B, Ogden A, Holman T (1989) MDL 27,777: a selective inhibitor of serotonin uptake. Soc Neurosci Abstr 14:223
12. Fuller RW, Perry KW, Molloy BB (1975) Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine. Eur J Pharmacol 33:119-124
13. Geyer MA, Swerdlow NS, Mansbach RS, Braff DL (1990) Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485-498
14. Greer G, Tolpert R (1986) Subjective reports of the effects of MDMA in a clinical setting. J Psychoact Drugs 18:319-327
15. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32:939-943
16. Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175-189
17. Hutson PH, Curzon G (1989) Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxy-tryptamine concentration and behavior. Br J Pharmacol 96:801-806
18. Invernizzi R, Bertorelli R, Consolo S, Garattini S, Samanin R (1989) Effects of the l isomer of fenfluramine on dopamine mechanisms in rat brain: further studies. Eur J Pharmacol 164:241-248
19. Judd LL, McAdams L, Budnick B, Braff DL (1992) Sensory gating deficits in schizophrenia: new result. Am J Psychiatry 4: 488-493
20. Karper LP, Freeman GK, Morgan CA, Grillon C, Charney DS, Krystal JH (1993) Prepulse inhibition of the acoustic startle response and measure of attention in schizophrenic subjects. Schizophr Res 9:160
21. Kehne JH, McCloskey TC, Taylor VL, Black CK, Fadayel GM, Schmidt CJ (1992) Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats. J Pharmacol Exp Ther 260:78-89
22. Kehne JH, McCloskey TC, Padich RA, Taylor VL, Schmidt CJ (1994) Serotonergic overactivation, like dopaminergic overactivation or glutamate underactivation, disrupts cross-modal sensory gating as measured by auditory and visual prepulse inhibition in rats. Soc Neurosci Abstr 20:1775
23. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther (in press)
24. 2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats. Neuropsychopharmacol (in press)
25. Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30:557-566
26. Krystal JH, Price LH, Opsahl C, Ricaurte GA, Heninger GR (1992) Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? Am J Drug Alcohol Abuse 18:331-341
27. Mansbach RS (1991) Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur J Pharmacol 202:61-66
28. Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507-514
29. Mansbach RS, Braff DL, Geyer MA (1989) Prepulse inhibition of the acoustic startle response is disrupted by N-ethyl-3,4-methylenedioxymethamphetamine (MDEA) in the rat. Eur J Pharmacol 167:49-55
30. Marshall BD Jr, Glynn SM, Midha KK, Hubbard JW, Bowen LL, Banzett L, Mintz J, Liberman RP (1989) Adverse effects of fenfluramine in treatment refractory schizophenia. J Clin Psychopharmacol 9:110-115
31. Meltzer H (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol Rev 43:587-604
32. 2 pKi values. J Pharmacol Exp Ther 251:238-246
33. Mongeau R, de Montgny C, Blier P (1994) Electro-physiological evidence for desensitization of a2-adrenoreceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentrations. Neuropsychopharmacology 10:41-51
34. 2A antagonist. Behav Brain Res 13:163-167
35. Padich RA (1993) Role of serotonin in an animal model of defective sensorimotor gating in schizophrenia. Doctoral Dissertation, Department of Psychology, University of Cincinnati, Cincinnati, Ohio
36. 2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology 124:107-116
37. 3 mediated control of dopaminergic function. In: Kahn RS (ed) Proceedings of American College of Neurophysiology Symposium. Psychopharmacology 112:S60-S67
38. Peroutka SJ, Newman H, Harris H (1988) Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology 1:273-277
39. Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS (1975) Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity. Drugs 10:241-323
40. Rigdon GC, Viik K (1991) Prepulse inhibition as a screening test for potential antipsycholics. Drug Dev Res 23:91-99
41. 1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486-493
42. Sanders-Bush E, Sterank LR (1978) Immediate and long-term effects of p-chloroamphetamine on brain amines. In: Jakoby JH, Lytle LD (eds) Serotonergic neurotoxins. Ann NY Acad Sci 305:208-221
43. Schecter MD (1988) Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Biochem Behav 31:817-824
44. Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1-7
45. Schmidt CJ, Kehne JH (1990) Neurotoxicity of MDMA: neurochemical effects. In: The neuropharmacology of serotonin. Ann NY Acad Sci 600:665-681
46. Schmidt CJ, Taylor VL (1990) Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur J Pharmacol 181:133-136
47. 2 receptor antagonist. MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine. Eur J Pharmacol 220:151-159
48. 2 receptors in schizophrenia and antipsychotic activity. Int Clin Psychopharmacol 8 [Suppl 2]:25-32
49. 2A receptors in antipsychotic activity. Life Sci 56:2209-2222
50. Schwartz D, Hernandez L, Hoebel BG (1989) Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis. Brain Res 482:261-270
51. Shimizu H, Bray GA (1989) Hypothalamic monoamines measured by microdialysis in rats treated with 2-deoxy-glucose or d-fenfluramine. Physiol Behav 46:799-807
52. Sipes TA, Geyer MA (1994) Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33:441-448
53. 2 receptor antagonist MDL 100,907 as a putative antipsychotic: behavioral, electrophysiological and neurochemical studies. J Pharmacol Exp Ther 266:684-691
54. Swerdlow NR, Mansbach RS, Geyer MA, Pulvirenti L, Braff DL (1990) Amphetamine disruption of prepulse inhibition of acoustic startle is reversed by depletion of mesolimbic dopamine. Psychopharmacology 100:413-416
55. Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, SCH 23390, and clozapine on apomorphine inhibition of sensorimotor gating of the startle reflex in the rat. J Pharmacol Exp Ther 256:530-536
56. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993) A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33:298-301
57. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995) Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58:192-200
58. 2-autoreceptors. Naunyn-Schmiedeberg's Arch Pharmacol 349:25-33
59. Yamamoto BK, Spanos LJ (1988) The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rats. Eur J Pharmacol 148:195-203